Lesson plan
TACSTD2
Tumor-associated calcium signal transducer 2 (Trop-2) is a protein that is encoded by the TACSTD2 gene. The protein was identified via the monoclonal antibody GA733 (giving the name GA733-1). It was separately characterized as an epithelial cell-surface antigen (EGP-1) that was later recognized as a calcium signal transducer (TACSTD2/Trop-2). This intronless gene is located at the short arm of chromosome 1 (1p32.1). It encodes a carcinoma-associated antigen that is closely related to epithelial cell adhesion molecule (EpCAM/TACSTD1). It transduces an intracellular calcium signal and acts as a cell surface receptor. It is expressed in low levels in normal epithelia but is overexpressed in the membranes of many epithelial-derived cancers, including breast (especially triple-negative breast cancer), lung, gastric, colorectal, pancreatic, and ovarian, cancers. High expression of TACSTD2 in cancer drives proliferation and is associated with worse outcomes. Mutations of this gene result in gelatinous drop-like corneal dystrophy, an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness.
Article summary
Tumor-associated calcium signal transducer 2 (Trop-2) is a protein that is encoded by the TACSTD2 gene. The protein was identified via the monoclonal antibody GA733 (giving the name GA733-1). It was separately characterized as an epithelial cell-surface antigen (EGP-1) that was later recognized as a calcium signal transducer (TACSTD2/Trop-2). This intronless gene is located at the short arm of chromosome 1 (1p32.1). It encodes a carcinoma-associated antigen that is closely related to epithelial cell adhesion molecule (EpCAM/TACSTD1). It transduces an intracellular calcium signal and acts as a cell surface receptor. It is expressed in low levels in normal epithelia but is overexpressed in the membranes of many epithelial-derived cancers, including breast (especially triple-negative breast cancer), lung, gastric, colorectal, pancreatic, and ovarian, cancers. High expression of TACSTD2 in cancer drives proliferation and is associated with worse outcomes. Mutations of this gene result in gelatinous drop-like corneal dystrophy, an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.